| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 26, 2001
From the Department of Pathobiology (E.B., C.-c.K., T.-M.L., L.A.C., F.B., B.C., M.E.R.) and the Interdisciplinary Graduate Program in Nutritional Sciences (F.B., M.E.R.), University of Washington, Seattle. * To whom correspondence should be addressed. E-mail: ssmjm{at}u.washington.edu.
BackgroundIt has not yet been determined whether lipid-loaded macrophages (foam cells), a major cellular component of atherosclerotic lesions, have the capacity to support growth of Chlamydia pneumoniae and be activated to secrete proinflammatory cytokines in response to C pneumoniae infection. Methods and ResultsLipid loading of RAW 264.7 cells and mouse peritoneal macrophages with either oxidized or acetylated LDL significantly inhibits the growth of C pneumoniae. Modified forms of LDL are not directly toxic to C pneumoniae and do not inhibit either the initial binding or internalization of C pneumoniae by macrophages. Lipid loading does not reduce infection of macrophages with Chlamydia trachomatis. Treatment of lipid-loaded macrophages with live, heat-killed, or UV-inactivated C pneumoniae stimulates secretion of cytokines. C pneumoniae also induces expression of the mRNA for tumor necrosis factor- ConclusionsFoam cell formation is not conducive to growth of C pneumoniae but does not inhibit the C pneumoniae--induced secretion of proinflammatory cytokines.
Revised on January 7, 2002
Accepted on February 5, 2002
Foam Cell Formation Inhibits Growth of
Chlamydia pneumoniae but Does
Not Attenuate Chlamydia
pneumoniae--Induced Secretion of Proinflammatory
Cytokines
Erwin Blessing MD,
in foam cells despite inhibition of nuclear factor-
B binding to DNA by prior treatment with oxidized LDL.
This article has been cited by other articles:
![]() |
S. Chen, R. Sorrentino, K. Shimada, Y. Bulut, T. M. Doherty, T. R. Crother, and M. Arditi Chlamydia pneumoniae-Induced Foam Cell Formation Requires MyD88-Dependent and -Independent Signaling and Is Reciprocally Modulated by Liver X Receptor Activation J. Immunol., November 15, 2008; 181(10): 7186 - 7193. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grunfeld and K. R. Feingold HDL and innate immunity: a tale of two apolipoproteins J. Lipid Res., August 1, 2008; 49(8): 1605 - 1606. [Full Text] [PDF] |
||||
![]() |
F. N. Wuppermann, K. Molleken, M. Julien, C. A. Jantos, and J. H. Hegemann Chlamydia pneumoniae GroEL1 Protein Is Cell Surface Associated and Required for Infection of HEp-2 Cells J. Bacteriol., May 15, 2008; 190(10): 3757 - 3767. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yaraei, L. A. Campbell, X. Zhu, W. C. Liles, C.-c. Kuo, and M. E. Rosenfeld Chlamydia pneumoniae Augments the Oxidized Low-Density Lipoprotein-Induced Death of Mouse Macrophages by a Caspase-Independent Pathway Infect. Immun., July 1, 2005; 73(7): 4315 - 4322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Kazemi, C. M. McDonald, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold Adipocyte Fatty Acid-Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1220 - 1224. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |